Project Grant R21AI188946
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$416K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Drexel University (XF3XM9642N96)
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This $797,735 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to elucidate the cellular and molecular mechanisms governing heightened immune responses in neonates. The research project will utilize a novel mouse model to investigate how the innate immune system detects and mediates sterile inflammation during early life development, with the goal of developing targeted...
This $2,654,646 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 Allergy and Infectious Diseases Research supports a multi-year program to better understand the unique characteristics of the human immune response in early life. The program aims to uncover genetic and developmental determinants of pediatric immunity, examine how immune parameters evolve over childhood, and elucidate how baseline immune states predict responses to...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,112,004 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The grant, effective September 1, 2024 through July 31, 2029, will support research to define the mechanistic features of Interleukin-27 (IL-27) signaling at the maternal-fetal interface that...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $456,390 to Wake Forest University Health Sciences to conduct research on regulating the immune response to an influenza vaccine in young infants. The key objectives are to understand how varying the duration of antigen delivery impacts the infant B and T cell responses, with the goal of improving the efficacy of influenza vaccines...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) program, provides $471,159 to the University of California, Irvine (UCI) to conduct research on the role of interferon lambda in alpha herpesvirus neuroinvasion. The research aims to elucidate the mechanisms of axonal responses to interferon lambda and their effects on viral invasion of the nervous system, as well as determine how these...
This federal Project Grant award of $643,718 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand how interferon-regulatory factors (IRFs) and STAT transcription factors remodel the epigenome and chromosome organization of macrophages to reprogram their immune responses. The research aims to: 1) dissect the roles of innate immune IRFs in de novo enhancer formation, 2)...
This $415,250 federal Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research conducted by the University of Rochester to investigate the role of a novel myeloid cell type, long-lived highly differentiated monocyte-derived cells (LDMs), in regulating lung-resident memory T cell (Trm) responses to recurrent influenza virus infection. The key objectives are to determine...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $793,102 to Wake Forest University Health Sciences (WFUHS) to investigate the interplay of maternal antibody and newborn vaccine responses to influenza virus. The goal is to effectively vaccinate young infants when maternal antibody levels are high, so that as maternal antibody wanes, a protective...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $596,115 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Washington University in St. Louis. This 5-year grant, effective August 1, 2025, will support research to understand the mechanisms and long-term impacts of persistent parainfluenza virus infection. The research aims to determine how the virus persists in hematopoietic cells, study the long-term effects on respiratory...
This federal Project Grant award, valued at $472,210.00 and effective June 23, 2025 through May 31, 2027, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research by the University of Massachusetts Medical School to investigate the spatiotemporal relationship between CD4+ T resident memory cells and neutrophil recruitment in the lungs during pneumonia in experienced...